Why this overlooked ASX 200 stock just got upgraded by 3 leading brokers to "buy"

The A-REIT sector finished the trading day in the black, but there's one stock in particular that's capturing the attention of brokers.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The listed real estate sector is finding support today, but there's one stock in particular that's capturing the attention of brokers.

The stock in the limelight is Charter Hall Group (ASX: CHC) as three leading brokers upgraded their recommendation on the stock to "buy" following its latest update released last week.

The Charter Hall share price jumped 2.5% to a two-month high of $8.10 when the S&P/ASX 200 Index (Index:^AXJO) added 1% on Monday.

More fuel in the tank

While the group may not be the best performer in the sector as the Stockland Corporation Ltd (ASX: SGP) share price surged 4.4% and the Vicinity Centres (ASX: VCX) increased 4% to $1.45, experts believe there's plenty of room for Charter Hall to outperform.

UBS is one that believes in the upside as it upgraded the stock to "buy" from "neutral".

"A concern of real estate valuations, funds flows/capital raisings and transactions in a COVID-19 world has seen CHC underperform the AREIT market by 11% over the past 3 months," said the broker who put a 12-month price target of $9.80 on the stock.

"On rebased earnings CHC is trading on a 14x PE multiplied with growth of 6% from FY21."

Limited retail exposure

The diversified property portfolio of the group will give some protection against the looming structural risks facing retail landlords.

Credit Suisse believes there is too much focus on Charter Hall's retail exposure.

"At 30 Apr 2020, CHC had A$18.0bn of Office and A$8.1bn of Industrial FUM pre any gross-up from its Long WALE exposure," said the broker.

"Importantly, we estimate Retail provides only ~25% of 'base' earnings (i.e. pre any performance or transaction fees)."

Credit Suisse lifted its rating on the stock to "outperform" from "neutral" with a 12-month price target of $9.17 a share.

One of the safest ASX property stocks you can buy

JP Morgan also took the opportunity to upgrade its call on Charter Hall to "overweight" from "neutral". There were a few reasons for this, including management's update that showed little impact from the coronavirus fallout on group earnings.

It also noted that the group is among the lowest risk and most defensive property stocks in the Australian real estate investment trust (A-REIT) sector.

Further, Charter Hall can grow its industrial platform through transactions like sale and leaseback and JP Morgan sees scope for the stock to re-rate.

The broker's price target on Charter Hall is $9 a share.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why 4DMedical, Megaport, Meteoric Resources, and Ramelius shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »